TGFB1 and B-cell non-Hodgkin lymphoma: Similarly, downregulation of TGFBR2 via promoter methylation in B-cell lymphomas confers resistance to TGFB mediated growth suppression, which is partially reversible in vitro with the demethylating agent azacitidine [101].